DrugMapper


Display Options: Drug type Therapeutic Area Route of administration Mechanism of Action Indication Status		Total: 43


Small molecule Approved RESPIRATORY ORAL Sinusitis; Liver Diseases; Bronchitis, Chronic; Kartagener Syndrome; Pulmonary Disease, Chronic Obstructive; Cystic Fibrosis; Respiratory Tract Diseases Cystic fibrosis transmembrane conductance regulator positive modulator


Small molecule Approved CARDIOVASCULAR; OTHER; RESPIRATORY ORAL HIV Infections; Anemia, Sickle Cell; Coronary Disease; Cystic Fibrosis; Raynaud Disease; Scleroderma, Localized; Scleroderma, Systemic; Ulcer; Familial Primary Pulmonary Hypertension; Hypertension; Hypertension, Pulmonary Soluble guanylate cyclase positive allosteric modulator


Antibody Approved RESPIRATORY INJECTION Diffuse Intrinsic Pontine Glioma; Genital Neoplasms, Female; Hepatitis D; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma, Mantle-Cell; Lymphoma, T-Cell; Mycosis Fungoides; Neoplasm Metastasis; Nerve Sheath Neoplasms; Neuroblastoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retroperitoneal Neoplasms; Sepsis; Sezary Syndrome; Triple Negative Breast Neoplasms; Adenocarcinoma; Adrenal Cortex Neoplasms; Basal Cell Nevus Syndrome; Biliary Tract Neoplasms; Carcinoid Tumor; Carcinoma; Carcinoma, Basal Cell; Carcinoma, Large Cell; Carcinoma, Merkel Cell; Carcinoma, Neuroendocrine; Carcinoma, Pancreatic Ductal; Carcinoma, Small Cell; Cholangiocarcinoma; Chordoma; Colonic Neoplasms; Colorectal Neoplasms; Endometrial Neoplasms; Fallopian Tube Neoplasms; Gastrointestinal Stromal Tumors; Glioma; Gliosarcoma; Hemangiosarcoma; Hematologic Neoplasms; Hepatitis B, Chronic; Histiocytoma, Malignant Fibrous; Inflammatory Breast Neoplasms; Leiomyosarcoma; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Leukoplakia, Oral; Liposarcoma; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Peripheral; Meningioma; Myelodysplastic Syndromes; Nasopharyngeal Neoplasms; Neoplasms, Germ Cell and Embryonal; Oligodendroglioma; Oropharyngeal Neoplasms; Osteosarcoma; Ovarian Neoplasms; Pancreatic Neoplasms; Peritoneal Neoplasms; Pituitary Neoplasms; Pneumonia, Viral; Prostatic Neoplasms; Pulmonary Disease, Chronic Obstructive; Rectal Neoplasms; Retroviridae Infections; Salivary Gland Neoplasms; Sarcoma, Kaposi; Severe Acute Respiratory Syndrome; Small Cell Lung Carcinoma; Squamous Cell Carcinoma of Head and Neck; Thyroid Neoplasms; Uterine Cervical Neoplasms; Adenocarcinoma of Lung; Brain Neoplasms; Breast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Esophageal Neoplasms; Glioblastoma; Head and Neck Neoplasms; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Lymphoma, Follicular; Mesothelioma; Multiple Myeloma; Prostatic Neoplasms, Castration-Resistant; Sarcoma; Skin Neoplasms; Stomach Neoplasms; Urinary Bladder Neoplasms; Urogenital Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Hodgkin Disease; Melanoma; Neoplasms Programmed cell death protein 1 inhibitor

Antibody

Approved

RESPIRATORY

INJECTION

Diffuse Intrinsic Pontine Glioma; Genital Neoplasms, Female; Hepatitis D; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma, Mantle-Cell; Lymphoma, T-Cell; Mycosis Fungoides; Neoplasm Metastasis; Nerve Sheath Neoplasms; Neuroblastoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retroperitoneal Neoplasms; Sepsis; Sezary Syndrome; Triple Negative Breast Neoplasms; Adenocarcinoma; Adrenal Cortex Neoplasms; Basal Cell Nevus Syndrome; Biliary Tract Neoplasms; Carcinoid Tumor; Carcinoma; Carcinoma, Basal Cell; Carcinoma, Large Cell; Carcinoma, Merkel Cell; Carcinoma, Neuroendocrine; Carcinoma, Pancreatic Ductal; Carcinoma, Small Cell; Cholangiocarcinoma; Chordoma; Colonic Neoplasms; Colorectal Neoplasms; Endometrial Neoplasms; Fallopian Tube Neoplasms; Gastrointestinal Stromal Tumors; Glioma; Gliosarcoma; Hemangiosarcoma; Hematologic Neoplasms; Hepatitis B, Chronic; Histiocytoma, Malignant Fibrous; Inflammatory Breast Neoplasms; Leiomyosarcoma; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Leukoplakia, Oral; Liposarcoma; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Peripheral; Meningioma; Myelodysplastic Syndromes; Nasopharyngeal Neoplasms; Neoplasms, Germ Cell and Embryonal; Oligodendroglioma; Oropharyngeal Neoplasms; Osteosarcoma; Ovarian Neoplasms; Pancreatic Neoplasms; Peritoneal Neoplasms; Pituitary Neoplasms; Pneumonia, Viral; Prostatic Neoplasms; Pulmonary Disease, Chronic Obstructive; Rectal Neoplasms; Retroviridae Infections; Salivary Gland Neoplasms; Sarcoma, Kaposi; Severe Acute Respiratory Syndrome; Small Cell Lung Carcinoma; Squamous Cell Carcinoma of Head and Neck; Thyroid Neoplasms; Uterine Cervical Neoplasms; Adenocarcinoma of Lung; Brain Neoplasms; Breast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Esophageal Neoplasms; Glioblastoma; Head and Neck Neoplasms; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Lymphoma, Follicular; Mesothelioma; Multiple Myeloma; Prostatic Neoplasms, Castration-Resistant; Sarcoma; Skin Neoplasms; Stomach Neoplasms; Urinary Bladder Neoplasms; Urogenital Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Hodgkin Disease; Melanoma; Neoplasms

Programmed cell death protein 1 inhibitor


Small molecule Approved ENT; IMMUNE SYSTEM; OTHER; RESPIRATORY ORAL Unknown Unknown


Combination Approved OTHER; PEDIATRICS; RESPIRATORY INHALATION Unknown Unknown


Combination Approved OTHER; RESPIRATORY ORAL Unknown Unknown


Combination Approved OTHER; RESPIRATORY INJECTION Unknown Unknown


Combination Approved OTHER; RESPIRATORY INHALATION Unknown Unknown